Cova322 (Anti-IL-17 & TNF-Alpha)
Product Specifications
Target
TNF-alpha
Applications
Apoptosis
Additionnal Information
Cova322 is a bispecific FynomAb targeting TNF and IL-17A, created by fusing a small anti-IL-17A Fynomer to the anti-TNF antibody adalimumab. It shows potent inhibition of TNF and IL-17A in vitro and in vivo, offering potential benefits for inflammatory disease treatment. M.W 161.9 kDa.
Storage Conditions
-80°C (avoid freeze-thaw cycles)
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
BNC472848-500 1x 500 µL
Fibronectin (Fn-3), CF647 conjugate, 0.1mg/mL
Sign In for Pricing
View Details 
BNC940096-100 1x 100 µL
Histone H1 (AE-4), CF594 conjugate, 0.1mg/mL
Sign In for Pricing
View Details 
BNC401683-100 1x 100 µL
Factor XIIIa (Coagulation Factor XIIIA Chain) (F13A1/1683), CF640R conjugate, 0.1mg/mL
Sign In for Pricing
View Details